What are we offering?
Bayer HealthCare dedicates grants for the validation of promising targets and offers to bring in expertise, tools and technologies to help develop your ideas.
There are two different types of grants: Support Grants and Focus Grants (see below for further details). The size of the individual grant will depend on the target specifics and the phase of validation, but is limited to a maximum of €125,000. Successful projects supported by the grant may lead to further collaborations. Please note that proposals can only be submitted via our submission platform on the website.
In addition to the financial support, successful applicants may benefit from the complementary expertise. Bayer HealthCare has a long-standing experience in drug discovery and development as well as a proven track record of collaborations with academic institutes, start-ups, and biotech companies.
Who is eligible to apply?
Researchers from universities, other academic research institutes and start-up companies from all over the world.
What types of grants are offered?
We intend to offer the following different types of grants, depending on the specifics of the target and its development phase.
Grant types do not need to be selected by the grant applicant.
The decision on grant allocation is made at the sole and absolute discretion of Bayer HealthCare.
What do we offer in addition to financial grants?
In addition to the financial grants we may support your further work on the target of interest (if selected) by providing expertise, tools and/or investigations. This may include:
There are two different types of grants: Support Grants and Focus Grants (see below for further details). The size of the individual grant will depend on the target specifics and the phase of validation, but is limited to a maximum of €125,000. Successful projects supported by the grant may lead to further collaborations. Please note that proposals can only be submitted via our submission platform on the website.
In addition to the financial support, successful applicants may benefit from the complementary expertise. Bayer HealthCare has a long-standing experience in drug discovery and development as well as a proven track record of collaborations with academic institutes, start-ups, and biotech companies.
Who is eligible to apply?
Researchers from universities, other academic research institutes and start-up companies from all over the world.
What types of grants are offered?
We intend to offer the following different types of grants, depending on the specifics of the target and its development phase.
- Support Grants (€5,000-€10,000) to further advance research on targets that are at a very early stage of discovery; fixed grant approval letter; IP rights remain with the applicant.
- Focus Grants (€10,000-€125,000) for more mature ideas, e.g. to address specific aspects of a target as a first step towards transferring it to the drug discovery process; fixed grant approval letter; IP rights remain with the applicant.
Grant types do not need to be selected by the grant applicant.
The decision on grant allocation is made at the sole and absolute discretion of Bayer HealthCare.
What do we offer in addition to financial grants?
In addition to the financial grants we may support your further work on the target of interest (if selected) by providing expertise, tools and/or investigations. This may include:
- Antibodies Bayer HealthCare’s Antibody Discovery unit may be able to support your target validation work. Often, for the most innovative target proposals, no suitable validation tools are available. To fill this gap, Bayer HealthCare routinely employs its state of the art antibody lead discovery platform to generate antibodies for target validation. Recombinant antibody engineering technologies are used. The turn-around time averages six months from project initiation until antibody delivery. Please indicate within your grant application which in vitro/in vivo models you intend to use during target validation and which requirements potential tool antibodies should fulfill.
- Small Molecule Tool Compounds Bayer HealthCare’s Compound Collection may provide valuable support for your target validation work. We may have chemical probes to support your validation efforts. Please indicate within your grant application which in vitro/in vivo models you intend to apply for target validation and which requirements potential tool compounds should fulfill.
- Biobank samples Samples from Bayer HealthCare’s Research Biobank may help to validate your target/biomarker. Bayer HealthCare’s Research Biobank contains tissue and blood samples from all indications in which grants are offered including oncology (mainly solid tumors), cardiology, and gynecology. We are aware of the socioethical aspects of this topic and deploy best practice with a particular focus on the informed consent of the donors. Please indicate in your grant application which specimen(s) might be helpful for the validation of your target and how, including relevant analytical techniques.
- Technologies The technology platforms and methods that are routinely used by Bayer HealthCare, may support your target/biomarker validation. If selected, we may offer you access to gene expression profiling or other up-to-date research technologies. Please detail your research interests with regard to the use of technology platforms in the submission platform.